Immune Tolerance Network

The Immune Tolerance Network (ITN) accepts applications for novel clinical trials from all interested scientists from academia, industry and government, in the areas of kidney & liver transplantation, autoimmune diseases, and allergy & asthma.

In addition, the ITN accepts applications for the development of novel tolerance assays or mechanistic studies for the purposes of establishing new surrogate markers of immune tolerance and investigating the mechanisms of clinical tolerance.

There is no deadline for submission of concept proposals; they are accepted throughout the year with reviews taking place several times per year. For more information please visit the ITN website.